SYK(Stryker Corporation) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $17.11B | $18.45B | $20.50B | $22.59B | $25.12B |
| 毛利润 | $10.97B | $11.58B | $13.06B | $14.44B | $16.07B |
| 营业利润 | $2.58B | $2.84B | $3.89B | $3.69B | $4.89B |
| 净利润 | $1.99B | $2.36B | $3.17B | $2.99B | $3.25B |
| 经营现金流 | $3.26B | $2.62B | $3.71B | $4.24B | $5.04B |
| 自由现金流 | $2.74B | $2.04B | $3.14B | $3.49B | $4.28B |
| 摊薄每股收益 | $5.21 | $6.17 | $8.25 | $7.76 | $8.40 |